|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Serum complement factor H is associated with clinical and pathological activities of patients with lupus nephritis显示文摘 | Wang FM Yu F Tan Y | | 0，，： | 1 |
| 2 | Identification and occurrence of tetrad-forming Alphaproteobacteria in anaerobic–aerobic activated sludge processes 显示文摘 | Wong MT Tan FM Ng WJ | 2004 | Microbiology2004，150，11： | 1 |
| 3 | Prevalence of peripheral abnor- malities on uhra-widefield greenlight(532 nm) autofluorescence imaging at a tertiary care center显示文摘 | Heussen FM Tan CS Sadda VR | 2012 | Invest Ophthalmol Vis Sci2012，53，10： | 1 |
| 4 | Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth显示文摘 | Yakes FM Chen J Tan J | 2011 | Mol Cancer Ther2011，10，12： | 1 |
| 5 | Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis显示文摘 | Tan MW Mahajan-Miklos S Ausubel FM | 1999 | Proc Natl Acad Sci USA1999，96，2： | 1 |
| 6 | Cabozantinib(XL184),a novel MET and VEGFR2 inhibitor,simultaneously suppresses metastasis,angiogenesis,and tumor growth显示文摘 | Yakes FM Chen J Tan J | 2011 | Mol Cancer Ther2011，10，12： | 1 |
| 7 | Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth 显示文摘 | Yakes FM Chen J Tan J | 2011 | Mol Cancer Ther2011，10，12： | 1 |
| 8 | Serum complement factor H is associated with clinical and pathological activities of patients with lupus neph显示文摘 | Wang FM Yu F Tan Y | 2012 | Rheumatology (Oxford)2012，51，12： | 1 |
| 9 | Cabozantinib (XL184) , a novel MET and VEGFR2 inhibitor, simuhaneously suppresses metastasis, angiogenesis, and tumor growth 显示文摘 | YAKES FM CHEN J TAN J | 2011 | Mol Cancer T- her2011，10，12： | 1 |
| 10 | Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metas- tasis, angiogenesis, and tumor growth 显示文摘 | Yakes FM Chen J Tan J | 2011 | Mol Cancer Ther2011，10，12： | 1 |
| 11 | Cabozantinib(XL184), a novel met and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth 显示文摘 | Yakes FM Chen J Tan J | 2011 | Mol Cancer Ther2011，10，12： | 1 |
| 12 | Cabozantinib(XL 184) , a novel MET and VEGFR2 inhibitor, simultaneously suppresses metasta- sis, angiogenesis, and tumor growth显示文摘 | Yakes FM Chen J Tan J | 2011 | Mol Cancer Ther2011，10，12： | 1 |
| 13 | The serum levels of connective tissue growth factor in patients with systemic lupus erythematosus and lupus nephritis显示文摘 | Wang FM Yu F Tan Y | 2014 | Lupus2014，23，7： | 1 |
| 14 | Cabozantinib (XL184),a novel MET and VEGFR2 inhibitor,simultaneously sup- presses metastasis,angiogenesis,and tumor growth显示文摘 | Yakes FM Chen J Tan J | 2011 | Mol Cancer Ther2011，10，12： | 1 |
| 15 | Cabozantinib (XL184),a novel MET and VEGFR2 inhibitor,simultaneously suppresses metastasis,angiogenesis,and tumor growth显示文摘 | Yakes FM Chen J Tan J | | 0，，12： | 1 |
| 16 | Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis显示文摘 | Tan MW Mahajan-Miklos S Ausubel FM | 1999 | Proc Natl Acad Sci USA1999，96，2： | 1 |
| 17 | Cabozantinib(XL184),a novel MET and VEGFR2 inhibitor,simultaneously suppresses metastasis,angiogenesis,and tumor growth显示文摘 | Yakes FM Chen J Tan J | | 0，，： | 1 |
| 18 | Smoking, MATRICS consensus cognitive battery and PS0 sensory gating in a Han Chinese population 显示文摘 | Tan SP Jie-Feng Cui Fan FM | 2014 | Drug Alcohol Depend2014，143，： | 1 |
| 19 | Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously sup-presses metastasis, angiogenesis, and tumor growth 显示文摘 | Yakes FM Chen J Tan J | 2011 | Mol Cancer Ther2011，10，12： | 1 |
| 20 | Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa-Caenorhabditis elegans pathogenesis model显示文摘 | Mahajan-Miklos S Tan Man W Rahme LG Ausubel FM | 1999 | Cell1999，96，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员